TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
TVRD
167 hedge funds and large institutions have $703M invested in Tvardi Therapeutics, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 44 increasing their positions, 48 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
167
Holders Change
+12
Holders Change %
+7.74%
% of All Funds
2.94%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.05%
New
31
Increased
44
Reduced
48
Closed
17
Calls
$52.7M
Puts
$20.5M
Net Calls
+$32.2M
Net Calls Change
+$21.8M
Top Buyers
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
+$6.19M |
| 2 |
Nuveen Asset Management
Chicago,
Illinois
|
+$5.22M |
| 3 |
PCM
Penserra Capital Management
Orinda,
California
|
+$4.29M |
| 4 |
Two Sigma Investments
New York
|
+$4.02M |
| 5 |
BCM
Burrage Capital Management
Boston,
Massachusetts
|
+$3.91M |
Top Sellers
| 1 |
CG
Carmignac Gestion
Paris,
France
|
-$13M |
| 2 |
First Manhattan
New York
|
-$10.6M |
| 3 |
EMG
ETF Managers Group
Summit,
New Jersey
|
-$6.57M |
| 4 |
RCP
Rho Capital Partners
New York
|
-$5.43M |
| 5 |
PM
Prosight Management
Dallas,
Texas
|
-$4.21M |
